26 related articles for article (PubMed ID: 8091246)
1. High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.
Hosing C; Saliba RM; Okoroji GJ; Popat U; Couriel D; Ali T; De Padua Silva L; Kebriaei P; Alousi A; De Lima M; Qazilbash M; Anderlini P; Giralt S; Champlin RE; Khouri I
Ann Oncol; 2008 Jun; 19(6):1166-71. PubMed ID: 18272911
[TBL] [Abstract][Full Text] [Related]
2. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
3. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.
Zinzani PL; Tani M; Molinari AL; Stefoni V; Zuffa E; Alinari L; Gabriele A; Bonifazi F; Salvucci M; Tura S; Baccarani M
Haematologica; 2002 Aug; 87(8):816-21. PubMed ID: 12161357
[TBL] [Abstract][Full Text] [Related]
5. Salvage therapy for patients with lymphoma.
Armitage JO; Vose JM; Bierman PJ; Bishop MR
Semin Oncol; 1994 Aug; 21(4 Suppl 7):82-5. PubMed ID: 8091246
[TBL] [Abstract][Full Text] [Related]
6. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapses in aggressive non Hodgkin's lymphoma.
Bosly A
Bull Cancer; 2004; 91(7-8):E261-73. PubMed ID: 15381464
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide in the treatment of lymphoma.
Coiffier B
Semin Oncol; 1996 Jun; 23(3 Suppl 7):2-7. PubMed ID: 8711498
[TBL] [Abstract][Full Text] [Related]
9. The role of allogeneic transplantation in non-Hodgkin's lymphoma.
Peggs KS; Mackinnon S; Linch DC
Br J Haematol; 2005 Jan; 128(2):153-68. PubMed ID: 15638849
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow transplantation for malignant lymphoma.
Appelbaum FR; Thomas ED
Eur J Cancer Clin Oncol; 1987 Mar; 23(3):263-6. PubMed ID: 3297717
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
